Combined oral contraception and treatment of new coronavirus infection (COVID-19): drug interaction issues

Abstract

Combined oral contraception and treatment of new coronavirus infection (COVID-19): issues of drug interaction This article examines the interaction of combined oral contraceptives with drugs recommended in the treatment of new coronavirus infection (COVID-19) at the pharmacodynamic and pharmacokinetic levels, with an assessment of the effectiveness and safety of therapy for the female body.

Keywords

• new coronavirus infection (covid-19)
• combined oral contraceptives
• antiviral
• antibacterial
• anti-inflammatory
• antithrombotic
• antimigrenous
• antihypertensive
• oral hypoglycemic
• medicinal products
• essential micronutrients
• pharmacodynamic and pharmacokinetic interaction